SUMMARY Plasma-and erythrocyte-selenium concentrations were determined in five consecutive patients with Crohn's disease given preoperative total parenteral nutrition -nil per os -for a mean period of 34 days per patient. No blood components were administered during the total parenteral nutriton. Before the total parenteral nutrition the plasma-selenium level and, to a less extent, the erythrocyte-selenium levels were below the reference values. After three weeks of total parenteral nutrition both concentrations had fallen. There were, however, clinical and biochemical signs of improvement during the total parenteral nutrition, as indicated by an increase in body weight, P-albumin and P-transferrin. In one female patient given 39 days of preoperative total parenteral nutrition containing 0-06 ,mol (5 ug) selenium per 24 h the decreasing levels of plasma-selenium and erythrocyte-selenium were both correlated to the duration of the total parenteral nutrition (r=0-87 and 0-96, respectively). The results suggest that total parenteral nutrition patients may be at risk for selenium deficiency, and that a supplementary administration of selenium via total parenteral nutrition may be required.
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Results
During total parenteral nutrition all five patients displayed clinical remission -as judged from their well-being, relief of abdominal pain and abatement of diarrhoea. Throughout the period of preoperative total parenteral nutrition the body weight increased significantly from 48±6 to 51±7 kg.
The results of the biochemical analyses are summarised in Table 2 . Throughout the period of preoperative total parenteral nutrition the Palbumin concentration increased from 30±3 to 38±4 g/l; the numerical decrease in P-orosomucoid from 1-7±0-5 to 1-3±0-4 g/l was not significant (p=0-08).
The results of the analyses of the selenium Table 3 . After three weeks of total parenteral nutrition the plasma-selenium and erythrocyte-selenium concentrations had decreased, even though both were below the reference values when total parenteral nutrition was introduced. In one female patient, who had the highest initial concentration of erythrocyte-selenium of all the patients, the concentrations of plasma-selenium and erythrocyte-selenium were both correlated to the duration of the preoperative total parenteral nutrition (r=0-87 and r=0-96, respectively) ( Figure) . Four analyses of the total parenteral nutrition solutions showed that she had received about 5 In the Crohn's disease patients of the present study there was a decrease in the plasma and erythrocyte concentrations of selenium during total parenteral nutrition, including commercially available infusion solutions but no supplementary selenium. This decrease is remarkable in view of the fact that the concentrations of selenium in the plasma and the erythrocytes point to selenium deficiency already at the time that total parenteral nutrition was introduced. The clinical significance of this degree of low blood selenium concentrations is, however, unknown. Though the total parenteral nutrition regimen obviously aggravated the deficiency of selenium, there was clinical and biochemical evidence of a nutritional improvement during the total parenteral nutrition, as indicated by the increase in body weight, P-albumin and P-transferrin. The possible concomitant abatement of the inflammation of the bowel, as reflected in the changes in the biochemical variables studied, was less convincing, as there was a decrease only in P-haptoglobin, and no significant change in P-orosomucoid.
The Neither a low dietary selenium intake nor a low blood selenium concentration has been found to be related to any specific pathologic condition in man.5 A low selenium concentration in serum, however, has been associated with an increased risk of gastrointestinal and prostatic cancer. 27 Selenium supplementation in patients on long term parenteral nutrition has received little attention, and no intravenous selenium preparation is commercially available in Sweden.
Because of the inter-subject variability and the potential toxicity of selenium32 it has been recommended that an assessment of the selenium status should be performed before adding the element to the infusion solution, and repeated at intervals during the administration of supplementary selenium.5
In view of the fact that, despite initially subnormal values, our patients showed a decrease in the plasma and erythrocyte selenium concentrations over so short a period of total parenteral nutrition as three weeks, and as our infusion solutions are poor in selenium, it would seem important to administer the element to selenium-deficient total parenteral nutrition patients. 
